The newly identified miR-142-5p–ARID2–DNMT1–IFN-γ–IDO axis in LECs appears to be a critical molecular mechanism underlying CSCC progression and may serve as a novel diagnostic and therapeutic target for CSCC patients at high risk of progression. Here, ARID2 is linked to skin squamous cell carcinoma.